Results 181 to 190 of about 169,884 (264)

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, Volume 20, Issue 3, Page 611-628, March 2026.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Nomogram model for prediction of pulmonary tuberculosis patients with intestinal tuberculosis. [PDF]

BMC Infect Dis
Liao N, Zhao Y, Long Y, Hu T, Shen Y.
europepmc   +1 more source

Dietary nitrate and nitrite protect against doxorubicin‐induced cardiac fibrosis and oxidative protein damage in tumor‐bearing mice

FEBS Open Bio, Volume 16, Issue 3, Page 584-594, March 2026.
Chemotherapies such as doxorubicin can have toxic effects on healthy cardiovascular/heart tissue. Following up on a doxorubicin toxicity study in mice without tumors where nitrate water was cardioprotective (lessened toxicity), this study with tumor‐bearing mice undergoing doxorubicin treatment showed no negative effect of nitrate and nitrite on drug ...
Rama D. Yammani, Xiaofei Chen, Nildris Cruz‐Diaz, Xuewei Zhu, Swati Basu, Daniel B. Kim‐Shapiro, David R. Soto‐Pantoja, Leslie B. Poole   +7 more
wiley   +1 more source

Nutritional status affects inflammatory responses and exacerbates the severity of pulmonary tuberculosis. [PDF]

Front Cell Infect Microbiol
Xia Q, Wang A, Zhang Y, Meng J, Wu S, Zhu P, Guo Z, Hou J, Wang H, Liu X.   +9 more
europepmc   +1 more source

Attenuated Bacteria‐Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies

Advanced Science, Volume 13, Issue 16, 18 March 2026.
This review comprehensively overviews attenuated bacteria‐based tumor therapy, highlighting key methodologies and recent progress. It examines strategies for enhancing safety, stabilizing efficacy, optimizing manufacturing, and navigating regulatory pathways.
Yucheng Liu, Junhong Yao, Jiaxin Deng, Minjie Zhou, Kaiyue Shen, Shishuo Sun, Xiaoge Gao, Qing Zhang, Haiheng Xu   +8 more
wiley   +1 more source

Ensemble deep learning architectures for detecting pulmonary tuberculosis in chest X-rays. [PDF]

Sci Rep
García Seco de Herrera A, Yagis E, Pinpo N, Abolghasemi V, Andritsch J, Chaichulee S, Dicente Cid Y, Ingviya T.   +7 more
europepmc   +1 more source

Gut Microbiota‐Non‐Coding RNA Axis in Immune Modulation and Disease: From Mechanisms to Clinical Translation

Advanced Science, Volume 13, Issue 16, 18 March 2026.
ABSTRACT Immune homeostasis is indispensable for preserving organismal integrity, orchestrated through complex molecular networks encompassing immune cell dynamics, microbial cues, and epigenetic regulation. Among these, the gut microbiota‐non‐coding RNA (ncRNA) axis has recently garnered substantial attention as a multifaceted modulator of host ...
Bonan Chen, Guoming Chen, Xieyuan Leng, Qianfan Li, Wenhao Wu, Wenqiu Wu, Zixuan Liu, Zilan Zhong, Xiaohong Zheng, Wei Kang, Fazheng Ren, Yigan Zhang, Juan Chen   +12 more
wiley   +1 more source

Spatial neighborhood patterns of pulmonary tuberculosis in a large urban area: the case of Santiago, Chile. [PDF]

Sci Rep
Ayala S, Escobar N, Vizeu Barrozo L, Chiaravalloti-Neto F, Canals M.   +4 more
europepmc   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, Volume 78, Issue 3, Page 566-581, March 2026.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

C-Reactive Protein for Pulmonary Tuberculosis Screening and Treatment Response Monitoring in Children. [PDF]

Open Forum Infect Dis
Githua J, Mecha J, Stern J, Escudero JN, Njagi L, Kijaro L, Mirera J, Murithi W, John-Stewart G, Maleche-Obimbo E, Nduba V, LaCourse SM.   +11 more
europepmc   +1 more source